血液净化护理杂志投稿经验

该杂志如何投稿

中国血液净化杂志怎么投稿可以把你的稿写好以后经过专家帮你审核以后确实觉得挺好，然后往中国血液净化杂志上投稿。

在欧美国家，血液净化早已成为人们健康护理的必备选项！在德国，血液净化疗法已经在保险允许范围内有着40年以上的使用历史，每年有超过20万人定期进行血液净化，许多公司白领、企业领导、国家领导人等每隔一段时间都会进行血液净化，以便及时排除体内堆积的毒素。血液净化是通过将人体血浆从血液中分离出来，然后通过独有的分子筛和具有生物吸附功能的纳米超离子纤维膜，进行分离或吸附的二级处理，直接清除血浆中的有毒有害等致病物质。当血液经过净化吸附滤芯后，致病因子会被吸附在滤芯中，从血液中隔离出来，健康血液又回流到体内。它能够有效降低胆固醇、改善血管弹性功能，清除血管凝集分子/发炎分子，降低血液粘稠度，清除致癌因子。去除血浆中代谢毒物，提高细胞活性，保护心肌，修复受损的血管，焕发机体生命力，有效防止早衰，预防心脑血管疾病等。目前该项目已纳入国内精准健康管理体系。

如果想投稿中国血液净化杂志，你可以按照他的要求以及程序往他的邮箱里直接投。

Blood purification pharmacokinetics Shanghai Jiaotong University College of Medicine subsidiary Ruijin Hospital kidney Chen Nan-J) N FWR; t Blood purification technology in clinical treatment of acute and chronic renal failure has been nearly half a century, and in critically ill patients, such as acute renal failure (ARF) in the treatment of continuous renal replacement therapy (CRRT) more traditional intermittent hemodialysis greater advantages, its clinical application is gradually expanded from the traditional kidney renal replacement to support development, participate in a multidisciplinary critical severe _ (HwU> Whether or ARF in patients with CRF usually kinds of medication, drugs in the application of these patients should be in accordance with its residual renal function adjustment, and at the same time, blood purification and changed the drug metabolism in patients with these conditions, particularly in critically ill patients, such as failure to consider this factor, medication adjustment programmes, the consequences could be Q: bKT # \ 1) from the following three aspects of the assessment of patients with blood purification P (rS - `I First, the nature of drug j1ZFsTFMWp 1, renal clearance in the proportion of drug: drug in the body's overall clearance rate is the body organ system capacity to remove the sum of drugs, including liver, kidney, as well as other metabolic If drugs mainly through kidney removal, which is usually to remove CRRT part of the in vitro clear / removal of the overall ≥ 25 ~ 30%, it is necessary to adjust the Pio ^ 5j hB6 2, protein binding rate: drug free with biological activity and can be removed filtration, plasma protein binding is the high rate of drugs (such as digitalis glycosides drug, warfarin, ) are difficult to remove CRRT Protein binding rate can be affected by many factors, the theoretical value and the actual situation may have some ! A! \ S / x4 3, molecular weight: small molecular diffusion easy to be adopted by dialysis membrane pore, drug removals and molecular size inversely proportional to macromolecules often convection through, unless more than its molecular weight film hole size, or ultrafiltration rate associated with the Most of the molecular weight of less than 500 drug Da, Da little more than Extension of high-flux dialysis membrane and time of removal can be improved 'T [zh # v> S 4, the volume of distribution (Vd): in vivo drug representatives of the extent of the Vd representative of the high rate of drug organizations with high clearance rate is Vd patients with severe and theoretical value can be very different, but there are individual Drug Vd ≤ 1 L / kg easy clearance, ≥ 2 L / kg difficult to be High flow could be higher IHD Vd drug rapidly cleared from plasma, serum concentration decreased, but only in a dialysis drug remove a small part in the two dialysis between plasma concentration will quickly CRRT continued slow clearance high Vd drugs, the process of drug plasma from the organizations to re-distribution, the change in the plasma concentration of ( 3, blood and dialysis fluid flow rate: the faster the velocity, the more easily access drug dialysis membrane into the dialysis solution in the dialysis fluid flow faster, drug dialysis fluid outflow from the faster to maintain the required gradient # J a `+ w) Third, the patient's own | (a] P = 9X, Cefaclor 1 25 24-35 25-5 tid not adjusted to 25 sU? "V Cefoperazone 6-5 90 14-20 1-2 q12h thoroughly after delivery without adjustment?,: # 9 Cefuroxime 2 33 13-18 75-5 q8h thoroughly after administration 0 q12h * i? RJH Ceftazidime 2 17 28-4 1-0 q8h 0 1-0 q24-48h YxE bg (Y Amikacin 4-3 <5 22-29 5mg/kg q12h 2 / 3 of the normal 30-70% q12-18h wI! + L & Q Tobramycin 5 <5 22-33 7mg/kg q8h 2 / 3 of the normal 30-70% q12h lC = N: = Mu Ciprofloxacin 3-6 20-40 5 5-75 q12h 25 q12h 2 q12h, $ h (fM8GC Levofloxacin 4-8 24-38 1-5 5 q24h 25-50% 50% + T, H & # Imipenem 1 13-21 17-3 5-0 q6h thoroughly after administration 50 percent - J "qrp Z ^ Vancomycin 6-8 10-50 47-1 5 q6h 5 q48-q24-96h 5% 48h c X: 3 30 4 losartan 50mg qd-q12h unclear hundred percent jq57C)) X 2 Benazepril 22 95 15 10mg qd not 50-75% uw K h Monopril 12 95 15 10mg qd not 100% [T'yc: = Atenolol 7 45-60 5-10 50-100mg qd 25-50mg 50% q48h s ULIrYRA The name of the drug half-life F Ze: co8Mu (H) protein binding 0zw + @ l ` (%) Vd `" a? A 5] k (L / Kg) renal function f) * NX After the normal dose HD ^ fs m6 f)) SUPPLEMENTARY of CRRT j ~ Q) F | i8 Carvedilol 5-8 95 1-2 25-50mg q12-24h not 100 percent [6AHaOhR ' Nifedipine 4-5 97 4 10-20mg q6-8h not 100%> s & XX, w Amlodipine 35-50 95 21 5mg qd not 100 percent 1p8: 1) q Felodipine 10-14 99 9-10 10mg qd not 100% gs? 8Wzh90 * Digoxin 36-44 20-30 5-8 25-5mg qd not 25-75% q36h H4t) + (: D ' Low-molecular-weight heparin 2-0 unclear 06-13 30-40mg bid unclear 100% p "2m9 0IO Warfarin 34-35 99 15 load 10-15 mg of 2-10 mg qd not iHPUmTus not -- Azathioprine 16-1 20 55-8 5-5mg/kg q24h 25mg/kg 75% yq?] V7 ~ Cyclophosphamide 4-5 14-20 5-1 1-5mg/kg qd 1 / 2 dose of 100% Z:! IX ^ q;) n Vincristine 1-5 75 5-11 4mg / sq m unclear 100% I! P4 (3skAB Prednisone 5-5 80 2 5-60mg qd not 100% X x_ tpC? Prednisolone 5-5 80 2 5-60mg qd need 100 percent OZf6/10O / A prednisone 9-0 40-60 2-5 4-48mg qd not 100 percent [@ / /) # 5v Insulin 2-4 5 15 Indefinite not 75% `([R j M` Acarbose 3-9 15 32 50-200mg tid unclear avoid / 'ZKST4 Effects of Fluvastatin small 5-1 98 42 2-10mg qd unclear 100% k O1)? DWpa Simvastatin 2> 95 mg qd unclear 5-40 unclear 100%

中国血液净化杂志怎么投稿可以把你的稿写好以后经过专家帮你审核以后确实觉得挺好，然后往中国血液净化杂志上投稿。